Skip to main content
. 2021 Jan 27;28(4):2423–2431. doi: 10.1016/j.sjbs.2021.01.040

Fig. 2.

Fig. 2

Structural representation of docked compounds in the binding pocket of SARS-CoV-2 Mpro. (A) Cartoon representation of Mpro with the selected three compounds along with co-crystallized inhibitor N3. (B) Surface potential view of Mpro binding pocket occupied by the selected compounds and N3.